Addressing Healthcare Challenges In The US: How C2-AI’s Solutions Are Making A Difference

In the U.S. and in other international markets, healthcare issues such as Acute Kidney Injury (AKI) tracking, low volume issues in hospitals, focus on cherry-picked Key Performance Indicators (KPIs), and siloed thinking by DRG (Diagnosis-Related Group) have been persistent problems. However, C2-Ai, a healthcare solutions provider, has been effectively addressing these challenges with their suite of offerings.

A Proven Approach to Improving Care and Reducing Costs

With published evidence and over 10 years of experience in 11 countries and dozens of hospitals, C2-Ai has developed and validated systems that accurately identify and reduce clinical variation, measure and predict variation, harm, and mortality in patient outcomes, and ultimately lead to significant cost reductions and better patient outcomes. What sets C2-Ai apart is their individualized approach that takes into account patient physiological characteristics and multiple triggers, allowing for tailored interventions to improve care and reduce costs. Moreover, C2-Ai's predictive tools help save lives and reduce both direct and long-term costs for healthcare providers, making their solutions transformative yet non-disruptive, with zero integration required.

Revolutionizing M&A Processes in Healthcare

One of the key advantages of C2-Ai's offerings is their ability to provide detailed and comprehensive reports on clinical activities, governance, safety, and patient quality measurements, making them effective tools in merger and acquisition (M&A) processes. In a recent M&A process between geographically located faith-based systems in the North region of the U.S., C2-Ai was chosen for its ease, speed, and reliable data analysis, offering precise and detailed reports on clinical activities and revealing major variations across sites and specialties. C2-Ai's insights also uncovered problematic specialties, highlighted issues with staff performance, and identified failings in business intelligence, particularly in tracking high-harm issues like AKI, which were previously overlooked. Such information proved invaluable in the M&A due diligence process and helped the organizations make informed decisions.

Driving High-Reliability Healthcare in the Midwest

In the Midwest region, C2-Ai's solutions were employed by an organization on a decade-long journey to high-reliability healthcare. The findings revealed an increasing acuity of patients over time, not reflected in reimbursement remuneration, and a range of variations across specialties and sites. C2-Ai also identified an excessive focus on surgical site infections (SSI) that resulted in oversight of other, more harmful complications, such as post-op chest infections. Additionally, C2-Ai's reporting structure uncovered avoidable harm in other clinical service lines or nursing units, which were not covered by the system's internal processes, and highlighted suboptimal use of ICU in terms of clinical and cost efficiency. The insights provided by C2-Ai also revealed interesting differences in outcomes by ethnicity, correlated to admitting case-mix and social/community factors, which could be utilized as relevant business intelligence. Furthermore, C2-Ai's solutions identified a small number of surgeons with unwarranted mortality rates and complication rates, which were not otherwise captured, and suggested relatively easy interventions to correct the issues.

Reducing Avoidable Harm in the South

In the South region, C2-Ai's solutions were implemented in a large tertiary facility and had a positive impact on reducing basic service line/nursing unit-based avoidable harm, leading to improved patient outcomes and cost savings. These examples demonstrate how C2-Ai's suite of offerings can be effectively utilized in different regions and for different purposes, providing actionable insights and interventions that drive positive changes in healthcare organizations.

A Transformative Impact on Healthcare

C2-Ai's solutions have been addressing significant healthcare challenges in the U.S. and other international markets by accurately identifying and reducing clinical variation, measuring and predicting patient outcomes, and providing actionable insights for improvement. With their individualized approach, published evidence of success, and proven track record in numerous hospitals and countries, C2-Ai's solutions have proven to be transformative in improving patient care and reducing costs. The detailed and comprehensive reports provided by C2-Ai's offerings also make them valuable tools in M&A processes, helping healthcare organizations make informed decisions. From identifying major variations across sites and specialties to uncovering avoidable harm and providing insights on outcomes by ethnicity, C2-Ai's solutions offer critical business intelligence that can drive positive changes in healthcare organizations.

Innovating for a Better Healthcare Future

As healthcare challenges continue to persist, C2-Ai's innovative solutions offer a data-driven approach to address clinical variation, harm, and mortality, leading to better patient outcomes and cost savings. With their proven expertise and experience, C2-Ai is making a significant difference in the U.S. and international healthcare markets, helping hospitals and healthcare providers improve care quality, reduce costs, and ultimately save lives.


#DataDrivenHealthcare #ClinicalVariation #HealthcareSolutions #PatientOutcomes #HealthcareTransformation #ReducingHarm #HealthcareAnalytics #QualityImprovement #CostSavings #InnovationInHealthcare


Learn More about C2-AI

Previous
Previous

C2-Ai: Transforming Healthcare with Precision Analytics